Gongwin Biopharm Holdings Co Ltd Sustainability Reports
Gongwin Biopharm Holdings Co., Ltd. is a clinical-stage biopharmaceutical company focused on developing novel anti-cancer drugs. The company utilizes its proprietary minimally invasive targeted tumor ablation technology to treat various solid tumors in humans and animals.
Sector: Manufacturing
Country: Taiwan
Exchange: Taipei Exchange
FIGI: BBG00FVJJ535
9 reports from 2018 to 2025
